ProTrials Research is a boutique contract research organization (CRO) that Jodi Andrews and Inger Arum founded in 1996. Both of them are still running the Mountain View, California, operation together, with Andrews as CEO and Arum as president. A certified women-owned business with 110 employees and contractors, the company is…more...

In a conference call with Wall Street analysts last week, Parexel chief Josef von Rickenbach outlined some of the company’s recent quarterly earnings and future outlook. ClinPage has this news brief with a few financial results. Elaborating on the press release, von Rickenbach said the dynamics in the contract research…more...

Perceptive Informatics is gearing up to go into overdrive on imaging. The technology division of Boston-area contract research organization (CRO) Parexel recently announced that it had amassed an A-list of imaging advisors, including big names from Georgetown University to Harvard Medical School. The goal: To keep its imaging-centric operations on…more...

ClinPage recently caught up with Miriam Shuchman, author of the New England Journal of Medicine’s recent analysis of the contract research organization (CRO) industry. Instead of rehashing the NEJM article from October, which still has the industry wincing, we asked Shuchman about the mood in academia. She spoke from her…more...

What are your company’s core activities? This is a key question for every sponsor and contract research organizations (CRO) on the clinical trial landscape. It’s time to move beyond buzz words and think strategically. It’s not news that the growth of outsourcing can be attributed to more activities being defined…more...

Janice Sidorick was working in regulatory affairs for a pharmaceutical company that was starting up a cardiology trial. As Sidorick recalls, there were 250 sites with 500 patients in five countries. Most of the sites were in the U.S., Canada and Eastern Europe, with a smattering in South Africa. Twenty,…more...

The recent New England Journal of Medicine (NEJM) article that criticized contract research organizations (CROs) was a roundhouse kick to the gut of that industry. The Oct. 4, 2007 article, written by New York psychiatrist and professor Miriam Shuchman, asserted that as CROs have expanded from $7 billion in revenues…more...

In a hurry to dramatically increase enrollment for a trial? Have traditional methods lost their effectiveness? Then consider a custom DVD for principal investigators and other research staff. It will get them more invested in what you’re doing and simultaneously provide compelling instruction. Instead of the usual monotonous production featuring…more...

If clinical trial data is music, both fluid and potentially dissonant, Peg Regan of PharmaPros is a sort of symphony conductor. She’s the firm’s president and CEO—and has seen plenty of instruments that can prove tricky to coordinate. The ability to combine streams of clinical data remains something that is…more...

The three founders of Integrium didn’t set out to start a contract research organization (CRO). It just ... happened. It was the mid-1990s. David Smith, Joel Neutel and Michael Weber were southern California-based clinical investigators. In the course of conducting their research at the Long Beach Veterans Affairs Medical Center,…more...